A relevant problem in meta-analysis concerns the possible heterogeneity between trial results. If a test of heterogeneity is not significant the trials are often considered to be "homogeneous" and the individual trial results are replaced by an overall mean effect size and its confidence interval ("equal effects model"). If the trials are heterogeneous the individual trial effect sizes are conserved ("fixed effects model"). In a more flexible approach ("random effects model"), each trial makes use of knowledge from the other trials so individual effect sizes are "shrunken" towards an overall mean effect size. The more flexible tool may be useful for doctors involved in a trial when the outcome of their individual trial differs markedly from...
Meta-analysis of heterogeneous clinical trials is currently sub-optimal. This is because there has b...
Abstract Background When investigating subgroup effec...
A meta-analysis (MA) combines similar studies resulting in a larger number of subjects to improve th...
Heterogeneity in meta-analysis describes differences in treatment effects between trials that exceed...
Inmeta-analysis, between-study heterogeneity indicates the presence of effect-modifiers and has impl...
Heterogeneity in meta-analysis can be caused by chance, methodological or clinical variations betwee...
This article shows that the interpretation of the random-effects models used inmeta-analysis to summ...
To conduct a meta-analysis, one needs to express the results from a set of related studies in terms ...
Case-mix heterogeneity across studies complicates meta-analyses. As a result of this, treatments tha...
In designing a randomized controlled trial, it has been argued that trialists should consider existi...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Case‐mix heterogeneity across studies complicates meta‐analyses. As a result of this, treatments tha...
A meta-analysis may provide more conclusive results than a single trial. The major cost of meta-anal...
The goal of a meta-analysis is not only to synthesize the information of selected studies, estimate ...
Meta-analysis of heterogeneous clinical trials is currently sub-optimal. This is because there has b...
Abstract Background When investigating subgroup effec...
A meta-analysis (MA) combines similar studies resulting in a larger number of subjects to improve th...
Heterogeneity in meta-analysis describes differences in treatment effects between trials that exceed...
Inmeta-analysis, between-study heterogeneity indicates the presence of effect-modifiers and has impl...
Heterogeneity in meta-analysis can be caused by chance, methodological or clinical variations betwee...
This article shows that the interpretation of the random-effects models used inmeta-analysis to summ...
To conduct a meta-analysis, one needs to express the results from a set of related studies in terms ...
Case-mix heterogeneity across studies complicates meta-analyses. As a result of this, treatments tha...
In designing a randomized controlled trial, it has been argued that trialists should consider existi...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Randomized clinical trials provide the most reliable estimates of the benefits and harms of treatmen...
Case‐mix heterogeneity across studies complicates meta‐analyses. As a result of this, treatments tha...
A meta-analysis may provide more conclusive results than a single trial. The major cost of meta-anal...
The goal of a meta-analysis is not only to synthesize the information of selected studies, estimate ...
Meta-analysis of heterogeneous clinical trials is currently sub-optimal. This is because there has b...
Abstract Background When investigating subgroup effec...
A meta-analysis (MA) combines similar studies resulting in a larger number of subjects to improve th...